Godoy, Luiz C <br/><br/>
Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Dec 2012 
 - 20373-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1218938109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinogens--metabolism<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm--physiology<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Melanoma--drug therapy<br/>Neoplasm Proteins--chemistry<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase Type II--metabolism<br/>Nitrosation